FCGR2A and cancer: Receiving operating characteristic (ROC) curves show the relative diagnostic performance of TEPs RSL24D1, HPSE, IFI27, LGALS3BP, CRYM, HBD, COL6A3, LAMB2, IFITM3, ARL2, FCGR2A, and KLHDC8B have predictive validation value for cancers.